ARTICLE | Clinical News
NeoPharm preclinical data
May 2, 2005 7:00 AM UTC
In a mouse xenograft model of pancreatic tumor, NEO6002, a gemcitabine-cardiolipin conjugate significantly inhibited tumor growth by 52% compared to 32% with Gemzar gemcitabine. Results also showed l...